Last reviewed · How we verify
NCT06110377: MMP
MALE HAIR LOSS - Treatment With Dutasteride Mesotherapy x Dutasteride MMP Technique (Injections With Tattoo Machine)
Phase 4 trial testing MESOTHERAPY (INJECTIONS WITH SYRINGE AND NEEDLE) in Androgenic Alopecia in 60 participants. Status unknown.
1 April 2024
Quick facts
| Lead sponsor | Clinica Dermatologica Arbache ltda |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 30 October 2023 |
| Primary completion | 1 April 2024 |
| Estimated completion | 2 April 2025 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- MESOTHERAPY (INJECTIONS WITH SYRINGE AND NEEDLE)
- MMP (INJECTIONS WITH A TATTOO MACHINE)
Conditions studied
- Androgenic Alopecia — all drugs for Androgenic Alopecia →
Sponsor
Clinica Dermatologica Arbache ltda
Who can join
Adults 18 to 65, male only, with Androgenic Alopecia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized clinical trial carried out on 60 Brazilian men, aged 18 to 65, with mild or moderate androgenetic alopecia. Two techniques for administering dutasteride will be compared, injected by syringes or needles or by needling through tattoo machines.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06110377
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Androgenic Alopecia
Currently open trials in the same condition.
- NCT07373054 — Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Androgenic Alopecia · NA · recruiting
- NCT07107841 — Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site) · NA · recruiting
- NCT07203599 — A Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes · Phase 1, PHASE2 · recruiting
- NCT06697080 — Umbilical Cord-derived Mesenchymal Stem Cell Exosomes on Hair Growth in Patients With Androgenetic Alopecia · NA · active not recruiting
- NCT05938569 — Computer-Assisted Hair Restoration Study Using ARTAS System · NA · recruiting
Other Clinica Dermatologica Arbache ltda trials
Trials by the same sponsor.
- NCT06079645 — Lichen Sclerosus - Treatment With Triamcinolone Acetonide: Injections (Syringe and Needle) x Micro Injections (MMP Techn · NA · completed
- NCT04046679 — Bleomycin Infusion (MMP®) to Repigment Achromic Scars · Phase 4 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06110377 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Clinica Dermatologica Arbache ltda
- Last refreshed: 1 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06110377.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing